The regenerative medicine industry has a communication problem, and it isn’t a scientific one. The field now broadly accepts that mesenchymal stem/stromal cells (MSCs) exert their effects largely through paracrine signaling rather than engraftment and differentiation, a reframing captured in Arnold Caplan’s proposal to rename them “medicinal signaling cells.” What hasn’t matured is the public’s understanding of any of it. [Read more…]
Role of ELISA Immunoassay Kits in Celiac Disease Antibody Detection
Celiac disease is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks the small intestine. It is triggered by the consumption of gluten, a protein found in wheat, barley and rye. The immune reaction damages the tiny finger-like projections (villi) lining the small intestine. As a result, it reduces the body’s ability to absorb nutrients from food. [Read more…]
Cell Therapy CDMO Cellipont Bioservices Celebrates Major Manufacturing Milestone: Releases 100th GMP Batch
Cell therapy CDMO reaches major manufacturing milestone approximately one year after initiating GMP operations at its Texas facility
THE WOODLANDS, Texas, July 28, 2026 — Cellipont Bioservices, a cell therapy contract development and manufacturing organization, announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas.
The achievement is especially significant given that Cellipont initiated GMP manufacturing operations at the facility in June 2025. Reaching 100 GMP batch releases in approximately one year reflects the strength of the company’s operational infrastructure, the growing demand from its clients, and the dedication of its cross-functional teams. [Read more…]
The Cost Of Stem Cell Therapy in 2026
How much is stem cell therapy today in 2026? According to analysis by BioInformant, the cost of stem cell therapy ranges from less than $5,000 for simple procedures to $25,000 or more for complex ones. In general, stem cell treatment procedures are paid out-of-pocket by patients, because they are not covered by medical insurance. The cost of platelet rich therapy (PRP), which can be used separately or in conjunction with stem cell therapy, is typically $500-700, but may be as high as $2,000 at some locations. [Read more…]
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
New agreement secures flexible and scalable manufacturing to support the U.S. commercial and global clinical supply of miv-cel
EMERYVILLE, Calif., and WALTHAM, Mass., July 27, 2026 — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, and ElevateBio, a technology-driven advanced therapy contract development and manufacturing organization (CDMO), today announced a manufacturing agreement for both U.S. commercial and global clinical supply of miv-cel (mivocabtagene autoleucel), Kyverna’s autologous CD19-directed CAR T-cell therapy. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 63
- Next Page »